Korsana Biosciences, Inc. Common Stock
KRSA
15 hedge funds and large institutions have $2.41M invested in Korsana Biosciences, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
7% more funds holding
Funds holding: 14 → 15 (+1)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.68% less ownership
Funds ownership: 39.49% → 38.81% (-0.68%)
30% less capital invested
Capital invested by funds: $3.42M → $2.41M (-$1.01M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$770 |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$580 |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$74 |
| 4 |
AWM
Activest Wealth Management
Aventure,
Florida
|
+$40 |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$26 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
-$8.65K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$370 |
| 3 |
Wells Fargo
San Francisco,
California
|
-$48 |
KRSA Hedge Fund Activity: Q2 2024 in Review
15 of the 6,936 institutional investors tracked by Wall St. Rank reported a position in Korsana Biosciences, Inc. Common Stock (KRSA) for Q2 2024, worth a combined $2.41M — down 30% from $3.42M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new KRSA positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 2 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $770. The largest seller was Artal Group, cutting an estimated $8.65K.
- 15 institutional investors held Korsana Biosciences, Inc. Common Stock (KRSA) as of Q2 2024, up from 14 in Q1 2024.
- Funds reported $2.41M of Korsana Biosciences, Inc. Common Stock stock for Q2 2024, down 30% quarter-over-quarter.
- 2 funds opened new Korsana Biosciences, Inc. Common Stock positions in Q2 2024 and 1 closed out, a net change of +1 holder.
- The largest Korsana Biosciences, Inc. Common Stock buyer in Q2 2024 was Geode Capital Management, an estimated $770 added.
- The largest Korsana Biosciences, Inc. Common Stock seller in Q2 2024 was Artal Group, an estimated $8.65K sold.
Based on aggregated 13F filings for Q2 2024.